Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02434354
Brief Title: A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

First Submitted : April 30, 2015
First Submitted that Met QC Criteria : May 4, 2015
First Posted : May 5, 2015 (Estimate)

Results First Submitted : March 6, 2020
Results First Submitted that Met QC Criteria : December 9, 2020
Results First Posted : January 5, 2021

Last Update Submitted that Met QC Criteria : December 9, 2020
Last Update Posted : January 5, 2021